BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16206073)

  • 21. HLA/KIR restraint of HIV: surviving the fittest.
    Bashirova AA; Thomas R; Carrington M
    Annu Rev Immunol; 2011; 29():295-317. PubMed ID: 21219175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection.
    Novitsky V; Wang R; Margolin L; Baca J; Moyo S; Musonda R; Essex M
    Virology; 2010 Jul; 403(1):37-46. PubMed ID: 20444482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.
    Julg B; Williams KL; Reddy S; Bishop K; Qi Y; Carrington M; Goulder PJ; Ndung'u T; Walker BD
    J Virol; 2010 Jun; 84(11):5540-9. PubMed ID: 20335261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyclonal expansion of cervical cytobrush-derived T cells to investigate HIV-specific responses in the female genital tract.
    Bere A; Denny L; Burgers WA; Passmore JA
    Immunology; 2010 May; 130(1):23-33. PubMed ID: 20201983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local replication of simian immunodeficiency virus in the breast milk compartment of chronically-infected, lactating rhesus monkeys.
    Permar SR; Kang HH; Wilks AB; Mach LV; Carville A; Mansfield KG; Learn GH; Hahn BH; Letvin NL
    Retrovirology; 2010 Feb; 7():7. PubMed ID: 20122164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection.
    Novitsky V; Wang R; Margolin L; Baca J; Kebaabetswe L; Rossenkhan R; Bonney C; Herzig M; Nkwe D; Moyo S; Musonda R; Woldegabriel E; van Widenfelt E; Makhema J; Lagakos S; Essex M
    PLoS One; 2009 Nov; 4(11):e7727. PubMed ID: 19890401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection.
    Ramduth D; Day CL; Thobakgale CF; Mkhwanazi NP; de Pierres C; Reddy S; van der Stok M; Mncube Z; Nair K; Moodley ES; Kaufmann DE; Streeck H; Coovadia HM; Kiepiela P; Goulder PJ; Walker BD
    PLoS One; 2009; 4(4):e5013. PubMed ID: 19352428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers.
    Shalekoff S; Meddows-Taylor S; Gray GE; Sherman GG; Coovadia AH; Kuhn L; Tiemessen CT
    AIDS; 2009 Apr; 23(7):789-98. PubMed ID: 19293686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.
    Goepfert PA; Lumm W; Farmer P; Matthews P; Prendergast A; Carlson JM; Derdeyn CA; Tang J; Kaslow RA; Bansal A; Yusim K; Heckerman D; Mulenga J; Allen S; Goulder PJ; Hunter E
    J Exp Med; 2008 May; 205(5):1009-17. PubMed ID: 18426987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women.
    Shalekoff S; Meddows-Taylor S; Schramm DB; Donninger SL; Gray GE; Sherman GG; Coovadia AH; Kuhn L; Tiemessen CT
    J Acquir Immune Defic Syndr; 2008 Jul; 48(3):245-54. PubMed ID: 18360285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.
    Rolland M; Heckerman D; Deng W; Rousseau CM; Coovadia H; Bishop K; Goulder PJ; Walker BD; Brander C; Mullins JI
    PLoS One; 2008 Jan; 3(1):e1424. PubMed ID: 18183304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 group M conserved elements vaccine.
    Rolland M; Nickle DC; Mullins JI
    PLoS Pathog; 2007 Nov; 3(11):e157. PubMed ID: 18052528
    [No Abstract]   [Full Text] [Related]  

  • 33. Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants.
    Thobakgale CF; Ramduth D; Reddy S; Mkhwanazi N; de Pierres C; Moodley E; Mphatswe W; Blanckenberg N; Cengimbo A; Prendergast A; Tudor-Williams G; Dong K; Jeena P; Kindra G; Bobat R; Coovadia H; Kiepiela P; Walker BD; Goulder PJ
    J Virol; 2007 Dec; 81(23):12775-84. PubMed ID: 17881456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.
    Leligdowicz A; Yindom LM; Onyango C; Sarge-Njie R; Alabi A; Cotten M; Vincent T; da Costa C; Aaby P; Jaye A; Dong T; McMichael A; Whittle H; Rowland-Jones S
    J Clin Invest; 2007 Oct; 117(10):3067-74. PubMed ID: 17823657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope.
    Schaubert KL; Price DA; Frahm N; Li J; Ng HL; Joseph A; Paul E; Majumder B; Ayyavoo V; Gostick E; Adams S; Marincola FM; Sewell AK; Altfeld M; Brenchley JM; Douek DC; Yang OO; Brander C; Goldstein H; Kan-Mitchell J
    J Immunol; 2007 Jun; 178(12):7756-66. PubMed ID: 17548613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV viral diversity and escape from cellular immunity.
    Frahm N; Brander C
    Curr Infect Dis Rep; 2007 Mar; 9(2):161-6. PubMed ID: 17324354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
    Geldmacher C; Currier JR; Herrmann E; Haule A; Kuta E; McCutchan F; Njovu L; Geis S; Hoffmann O; Maboko L; Williamson C; Birx D; Meyerhans A; Cox J; Hoelscher M
    J Virol; 2007 Mar; 81(5):2440-8. PubMed ID: 17182686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control.
    Zuñiga R; Lucchetti A; Galvan P; Sanchez S; Sanchez C; Hernandez A; Sanchez H; Frahm N; Linde CH; Hewitt HS; Hildebrand W; Altfeld M; Allen TM; Walker BD; Korber BT; Leitner T; Sanchez J; Brander C
    J Virol; 2006 Mar; 80(6):3122-5. PubMed ID: 16501126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.
    Ramduth D; Chetty P; Mngquandaniso NC; Nene N; Harlow JD; Honeyborne I; Ntumba N; Gappoo S; Henry C; Jeena P; Addo MM; Altfeld M; Brander C; Day C; Coovadia H; Kiepiela P; Goulder P; Walker B
    J Infect Dis; 2005 Nov; 192(9):1588-96. PubMed ID: 16206073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.